Patents by Inventor Laura Colgin

Laura Colgin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070092865
    Abstract: This invention relates to methods and devices for the detection and characterization of psychoactive compounds by analyzing alterations of network level physiological characteristics before and after the introduction of a candidate sample onto an in vitro neuronal tissue sample. The invention further provides a software package that enables an operator to deliver a timed electrical pulse to neuronal samples at a specific point in their spontaneous or induced oscillations. Such temporal stimulations trigger unexpected and useful network level physiological responses.
    Type: Application
    Filed: November 15, 2006
    Publication date: April 26, 2007
    Inventors: Gary Lynch, Laura Colgin, Rafael Saavedra
  • Publication number: 20050228019
    Abstract: The present invention relates to a method for enhancing the physiological and therapeutic effects of an AMPA receptor potentiator in an animal by co-administration of an acetylcholinesterase inhibitor with the potentiator. Also disclosed is a method for treating a cognitive disorder in an animal by co-administration of an AMPA receptor potentiator and an acetylcholinesterase inhibitor. In addition, a composition comprising an effective amount of an AMPA receptor potentiator and an effective amount of an acetylcholinesterase inhibitor is also disclosed.
    Type: Application
    Filed: January 26, 2005
    Publication date: October 13, 2005
    Applicants: Cortex Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: Ursula Staubli, Gary Lynch, Sheng Zhong, Laura Colgin
  • Publication number: 20040137515
    Abstract: This invention relates to methods for the detection and characterization of psychoactives in neuronal tissue by comparing parameters measured for a set of baseline oscillations with those same parameters measured for a set of resulting oscillations. The baseline oscillations are induced or stimulated by such agents as chemical compounds that effect cholinergic interactions, co-deposited neuronal tissue, or electrical stimulations. The resulting set of oscillations is obtained after exposing the neuronal tissue to a sample composition that may or may not contain a psychoactive. By comparing the parameters for the baseline and resulting oscillations, the psychoactive in the sample composition may be detected and characterized as belonging to a specific psychoactive compound class and in some instances, may be distinguished from other members of the psychoactive compound class.
    Type: Application
    Filed: January 27, 2003
    Publication date: July 15, 2004
    Inventors: Gary Lynch, Makoto Taketani, Ken Shimono, Hirokazu Sugihara, Laura Colgin, Yousheng Jia